(Q73794746)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812043%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

title

Fluoxetine prevents PCP- and MK801-induced HSP70 expression in injured limbic cortical neurons of rats (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812043%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference

M Tomitaka

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812043%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

S Tomitaka

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812043%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

S Rajdev

series ordinal

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812043%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

F R Sharp

series ordinal

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812043%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

publication date

1 May 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812043%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

published in

Biological Psychiatry

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812043%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

volume

47

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812043%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

issue

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812043%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

page(s)

836-841

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812043%20AND%20SRC:MED&resulttype=core&format=json

Combination treatment with clozapine and paroxetine in schizophrenia: safety and tolerability data from a prospective open clinical trial

6 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900323-6

M100907, a selective 5-HT2A receptor antagonist and a potential antipsychotic drug, facilitates N-methyl-D-aspartate-receptor mediated neurotransmission in the rat medial prefrontal cortical neurons in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900323-6

Pleiotropic behavior of 5-HT2A and 5-HT2C receptor agonists

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900323-6

The glutamatergic dysfunction hypothesis for schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900323-6

Agonist activity of LSD and lisuride at cloned 5HT2A and 5HT2C receptors

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900323-6

Olanzapine and fluperlapine mimic clozapine in preventing MK-801 neurotoxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900323-6

Serotonergic agents that activate 5HT2A receptors prevent NMDA antagonist neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900323-6

Antipsychotic drugs block phencyclidine receptor-mediated neurotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900323-6

Are serotonin selective reuptake inhibitors effective in underweight anorexia nervosa?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900323-6

A placebo-controlled trial of D-cycloserine added to conventional neuroleptics in patients with schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900323-6

Selective serotonin reuptake inhibitors in the treatment of affective disorders--III. Tolerability, safety and pharmacoeconomics

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900323-6

Efficacy of high-dose glycine in the treatment of enduring negative symptoms of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900323-6

Recent advances in the phencyclidine model of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900323-6

Subanesthetic effects of the noncompetitive NMDA antagonist, ketamine, in humans. Psychotomimetic, perceptual, cognitive, and neuroendocrine responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900323-6

The synergistic effect of fluoxetine on the locomotor hyperactivity induced by MK-801, a non-competitive NMDA receptor antagonist

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900323-6

NMDA receptor function and human cognition: the effects of ketamine in healthy volunteers.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900323-6

Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900323-6

Interactions of selective serotonin reuptake inhibitors with subtypes of sigma receptors in rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900323-6

Pathological changes induced in cerebrocortical neurons by phencyclidine and related drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900323-6

NMDA Antagonist Neurotoxicity: Mechanism and Prevention

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900323-6

Fluvoxamine treatment of obsessive-compulsive symptoms in schizophrenic patients: an add-on open study.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900323-6

Behavioral profiles of SSRIs in animal models of depression, anxiety and aggression. Are they all alike?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900323-6

Phencyclidine induction of the hsp 70 stress gene in injured pyramidal neurons is mediated via multiple receptors and voltage gated calcium channels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900323-6

Haloperidol prevents induction of the hsp70 heat shock gene in neurons injured by phencyclidine (PCP), MK801, and ketamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900323-6

MK-801 and ketamine induce heat shock protein HSP72 in injured neurons in posterior cingulate and retrosplenial cortex

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900323-6

Phencyclidine (PCP) acts at sigma sites to induce c-fos gene expression.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900323-6

Augmentation with fluvoxamine but not maprotiline improves negative symptoms in treated schizophrenia: evidence for a specific serotonergic effect from a double-blind study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900323-6

Quantification of a neurotrophin receptor from submilligram quantities of brain tissue using western blotting

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900323-6

Memantine induces heat shock protein HSP70 in the posterior cingulate cortex, retrosplenial cortex and dentate gyrus of rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900323-6

Regionally different effects of scopolamine on NMDA antagonist-induced heat shock protein HSP70.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900323-6

D-serine added to antipsychotics for the treatment of schizophrenia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900323-6

Psychotropic drug prescription in a psychiatric university hospital.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900323-6

Eliprodil prevents expression of the 70 kDa heat shock protein in MK801-injured neurones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900323-6

Addictive Drugs and Brain Stimulation Reward

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900323-6

Neurobiology of addiction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900323-6

Schizophrenia and glutamatergic transmission

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900323-6

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/S0006-3223(99)00323-6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10812043%20AND%20SRC:MED&resulttype=core&format=json

6 November 2019

1 reference